Geulah Livshits
Stock Analyst at Chardan Capital
(4.22)
# 1,502
Out of 4,630 analysts
654
Total ratings
36.5%
Success rate
8.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGX Metagenomi Therapeutics | Maintained: Buy | $7 → $5 | $1.23 | +306.50% | 8 | Jul 7, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $157.77 | +52.12% | 12 | May 20, 2026 | |
| IMTX Immatics | Reiterated: Buy | $25 | $9.65 | +159.07% | 22 | May 19, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $20 | $4.51 | +343.46% | 15 | May 19, 2026 | |
| SNTI Senti Biosciences Holdings | Reiterated: Buy | $13 → $12 | $0.3537 | +3,292.71% | 12 | May 15, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $8 | $0.7268 | +1,000.72% | 21 | May 15, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $15 | $8.39 | +78.78% | 12 | May 13, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $17 | $4.81 | +253.43% | 13 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $3.61 | +204.71% | 39 | May 10, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $26 | $10.75 | +141.86% | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.08 | +192.21% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $6.34 | +120.82% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $6.56 | +82.93% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $4 | $2.88 | +38.89% | 43 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $14.00 | +57.14% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $53.52 | +42.00% | 57 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $326.45 | -1.06% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $30 | $11.94 | +151.26% | 51 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $21 | $4.40 | +377.27% | 17 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $59.17 | - | 41 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €1.00 | €0.29 | +246.02% | 8 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7 | $2.00 | n/a | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.63 | n/a | 23 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $13.07 | n/a | 18 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $46.42 | n/a | 6 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.79 | n/a | 11 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7753 | n/a | 12 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.67 | n/a | 3 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $9.14 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €15.00 | €0.09 | n/a | 7 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $76 | $10.72 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $6 | $3.27 | n/a | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $15 | $15.60 | n/a | 10 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $39.95 | n/a | 3 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.0127 | n/a | 5 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $25.03 | n/a | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 17 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $48 | $12.06 | n/a | 9 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $0.9001 | n/a | 1 | Jun 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $76.79 | n/a | 10 | Feb 20, 2020 |
Metagenomi Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $7 → $5
Current: $1.23
Upside: +306.50%
Palvella Therapeutics
May 20, 2026
Reiterated: Buy
Price Target: $240
Current: $157.77
Upside: +52.12%
Immatics
May 19, 2026
Reiterated: Buy
Price Target: $25
Current: $9.65
Upside: +159.07%
Immuneering
May 19, 2026
Reiterated: Buy
Price Target: $20
Current: $4.51
Upside: +343.46%
Senti Biosciences Holdings
May 15, 2026
Reiterated: Buy
Price Target: $13 → $12
Current: $0.3537
Upside: +3,292.71%
Tenaya Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.7268
Upside: +1,000.72%
Solid Biosciences
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $8.39
Upside: +78.78%
Lexeo Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $17
Current: $4.81
Upside: +253.43%
Rocket Pharmaceuticals
May 10, 2026
Reiterated: Buy
Price Target: $11
Current: $3.61
Upside: +204.71%
4D Molecular Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $26
Current: $10.75
Upside: +141.86%
May 8, 2026
Reiterated: Buy
Price Target: $9
Current: $3.08
Upside: +192.21%
May 7, 2026
Reiterated: Buy
Price Target: $16 → $14
Current: $6.34
Upside: +120.82%
May 6, 2026
Reiterated: Buy
Price Target: $12
Current: $6.56
Upside: +82.93%
May 5, 2026
Reiterated: Buy
Price Target: $3.5 → $4
Current: $2.88
Upside: +38.89%
May 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $14.00
Upside: +57.14%
May 4, 2026
Reiterated: Buy
Price Target: $76
Current: $53.52
Upside: +42.00%
May 4, 2026
Reiterated: Buy
Price Target: $323
Current: $326.45
Upside: -1.06%
Apr 27, 2026
Maintained: Buy
Price Target: $27 → $30
Current: $11.94
Upside: +151.26%
Nov 12, 2025
Maintained: Buy
Price Target: $120 → $21
Current: $4.40
Upside: +377.27%
Oct 7, 2025
Rated: Hold
Price Target: n/a
Current: $59.17
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: €1.00
Current: €0.29
Upside: +246.02%
Mar 24, 2025
Maintained: Buy
Price Target: $11 → $7
Current: $2.00
Upside: n/a
Jan 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.63
Upside: n/a
Dec 21, 2023
Reiterated: Buy
Price Target: $41 → $36
Current: $13.07
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $46.42
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $12
Current: $2.79
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.7753
Upside: n/a
Jan 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.67
Upside: n/a
Dec 14, 2022
Maintained: Buy
Price Target: $11
Current: $9.14
Upside: n/a
Jul 28, 2022
Reiterated: Buy
Price Target: €15.00
Current: €0.09
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $90 → $76
Current: $10.72
Upside: n/a
Mar 9, 2022
Reiterated: Hold
Price Target: $4 → $6
Current: $3.27
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: $25 → $15
Current: $15.60
Upside: n/a
Jan 5, 2022
Reiterated: Buy
Price Target: $22 → $20
Current: $39.95
Upside: n/a
Dec 17, 2021
Reiterated: Buy
Price Target: $30
Current: $0.0127
Upside: n/a
Aug 20, 2021
Reiterated: Buy
Price Target: $18 → $21
Current: $25.03
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 14, 2020
Maintained: Buy
Price Target: $30 → $48
Current: $12.06
Upside: n/a
Jun 4, 2020
Initiated Coverage: Buy
Price Target: $28
Current: $0.9001
Upside: n/a
Feb 20, 2020
Reiterated: Hold
Price Target: $1
Current: $76.79
Upside: n/a